© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Latamoxef Sodium goes back to days when the world needed stronger answers to infections. Developed in the late 1970s amid a burst of cephalosporin research, its core structure represents a turning point from simple β-lactam antibiotics. The push for Latamoxef came from real and urgent needs: growing resistance among hospital-acquired pathogens. Japanese scientists at Takeda Pharmaceutical spearheaded its synthesis—rethinking the oxacephem ring system—tweaking classic cephalosporin chemistry to create a wider, tougher spectrum. As hospitals faced more resistant bugs like Klebsiella and E. coli, the arrival of Latamoxef Sodium brought hope for effective control. Marketed under names such as Moxalactam, it found quick relevance in both Asia and Europe. In the United States, its FDA approval in 1980 signaled a new tool for clinicians dealing with tough Gram-negative infections.
Latamoxef Sodium stands out because it rewrites old ideas about what a β-lactam can do. As a broad-spectrum, semisynthetic antibiotic, it works by targeting bacterial cell wall synthesis—a direct punch to microbial survival. Packaged most often as a pale, sterile powder for reconstitution, Latamoxef Sodium can slip into hospital workflows. The sodium salt form boosts solubility, turning complicated dosing into a manageable task. Doctors have relied on its predictability in cases involving meningitis, respiratory tract infections, complicated urinary tract infections, intra-abdominal infections, and more. Its ability to cross the blood-brain barrier broadens its utility, especially for central nervous system infections. Some folks remember using it as a backup when other cephalosporins and penicillins no longer seemed to work.
Latamoxef Sodium brings a unique chemical backbone to the antibiotic lineup. Unlike classic cephalosporins, its molecular structure swaps a sulfur for an oxygen atom in the dihydrothiazine ring, classifying it as an oxacephem. This subtle rearrangement changes how the drug behaves, and it’s more than a textbook curiosity. With a molecular formula of C20H16N8Na2O10S, and a weight roughly around 630 g/mol as the sodium salt, Latamoxef dissolves freely in water, forming clear solutions for IV or IM use. Crystalline and nearly white, it avoids clumping and resists light degradation. Its melting range runs high, making it a stable shelf item. The sodium ion ensures the injectable form achieves consistent absorption and activity.
Each vial typically holds doses calibrated as Latamoxef Sodium equivalent; every milligram counts toward the patient’s regimen, so labels spell out potency exactly. U.S. packaging has long required listing the chemical equivalent to the base form, storage below 25°C, and strict monitoring of light exposure. Directions for dilution and administration are non-negotiable, since deviations can wreck both the drug’s power and patient safety. Package inserts detail potential interactions, administration intervals, and whether the solution requires use within strict timeframes post-reconstitution. The labeling process involves full traceability—from batch number down to expiry date—anchoring reliability and accountability.
Production of Latamoxef Sodium does not cut corners. Starting with fermentation-derived cephalosporin precursors, chemists introduce the oxygen ring via a controlled synthetic cascade. Key steps include acylation, ring expansion, and careful crystallization. Each step balances speed with purity, since impurities can trigger allergic reactions or reduce therapeutic effect. Conversion to the sodium salt means using sodium hydroxide under cool, dry conditions, then drying the resulting powder under vacuum. The final filtration and aseptic filling demands high-grade stainless steel gear and 24/7 monitoring for contamination. Many manufacturers build special isolation rooms for filling and sealing, wrapped with HEPA filters to keep out stray spores.
Chemists have long tinkered with the oxacephem skeleton in hopes of finding more potent or less toxic siblings to Latamoxef. Changes to the 7-acyl side chain or the 3-position group noticeably alter antimicrobial punch and pharmacokinetics. Substituting aromatic or heterocyclic moieties has delivered some lab wins, though not every experiment hits clinical shelves. Researchers keep an eye on β-lactamase resistance—tweaking groups to keep out stubborn enzymes. Some projects focused on combinatory chemistry, fusing β-lactam elements with other antibiotic classes to trip up bacterial counterattacks. In each case, every new variant cycles through standard susceptibility plates, stability checks, and toxicity screens before drawing clinical attention.
Pharmacists and doctors have seen Latamoxef Sodium labeled many ways across markets: Moxalactam sits at the front in the US; in some European hospitals, Latamoxef or Latamoxef Sodium appears on order sheets. Japan, where its journey began, sometimes refers to it as Moxalactamum Natricum. Global nomenclature can complicate imports, especially in multilingual regions—an issue for field hospitals and international relief work. Generic versions often present as “Latamoxef Sodium for Injection,” keeping the essential details clear, if less catchy.
No antibiotic with Latamoxef’s potency comes without serious responsibilities. Hospitals enforcing stewardship codes reserve it for cases where lower-generation drugs fail. Allergy risks—especially for people with known β-lactam or cephalosporin history—push prescribers to run screens and keep anaphylaxis kits close. Hemorrhagic side effects have haunted this drug, linked to interference with vitamin K metabolism; patients with coagulopathy risks demand extra caution, sometimes requiring supplementation. Operationally, mixing and administering calls for clean technique, as even a microbe can spoil the best powder. Nurses check batch dates, mix under sterile hoods, and double-check patient IDs before injection. Regulations in the US and EU demand traceback to every vial and clear guidance for disposal, since residues can disturb wastewater and select for resistant strains.
Doctors have chosen Latamoxef Sodium in their hardest fights: sepsis, joint infections (including prosthetic replacements), central nervous system infections, and post-surgical complications where Gram-negative bacteria dominate. Pediatricians have sometimes relied on it for neonatal sepsis, where speed matters. Surgery teams have used it both for treatment and as pre-op prophylaxis in high-risk environments. Intensive care units sometimes pick Latamoxef when outbreaks strain the hospital’s usual antibiotic stockpile. Its use has dropped since newer agents arrived, but in places with resistant infections and limited drug options, Latamoxef still plays a role.
Work never stops on Latamoxef and its kin. Years of clinical trials forced a close look at efficacy, spectrum, and real-side adverse events. Early enthusiasm gave way to concern about some rare, serious reactions, fueling calls for improved monitoring and refinement. Academic labs still test derivatives hoping for broader coverage or milder side effects, looking both at in-vitro plates and in-vivo models. New delivery forms—like depot injections or combination therapies—have emerged in journals, if not always on pharmacy shelves. Researchers frequently compare the cost, resistance dynamics, and outcome data against newer cephalosporins to argue for or against continued use. In regions where resistance to carbapenems or aminoglycosides runs high, revisiting Latamoxef in larger studies draws interest from public health officials.
Early animal and clinical studies shed light on both the power and risks of Latamoxef Sodium. The most troubling toxicity involves bleeding disorders—patients can develop hypoprothrombinemia, sometimes leading to bleeding complications. Scientists traced this to the drug’s tendency to interfere with vitamin K-dependent steps in clotting. Studies flagged additional risks, including allergic reactions and the usual mix of β-lactam upsides and downsides like gastrointestinal upset, rash, and rare potential for nephritis. Long-term toxicity studies in rodents ruled out major carcinogenicity, but human therapeutic windows remain narrow. Most protocols recommend close patient monitoring—especially among the frail or those with impaired kidney function. The need for vitamin K supplementation, especially for those predisposed to clotting issues, entered guidelines based on real-world data, not just lab results.
Nobody can promise where Latamoxef Sodium will stand in the coming years. Resistance to older drugs creates fresh pressure to use anything effective, even if it comes with trade-offs. The experience of older clinicians who remember treating untreatable infections with Latamoxef counts for something—familiarity with dosing, side effects, and the right moment for escalation. Efforts to re-engineer the molecule or pair it with protective agents against β-lactamases may stretch its relevance, offering second chances in a new era. Global health emergencies, natural disasters, and changing resistance maps remind everyone it pays to keep “old” options in play, especially for pathogens ducking past today’s most trusted drugs. New research may reimagine Latamoxef Sodium for topical, depot, or even oral formulations. Its story remains open-ended, a reminder that the world’s pharmacology toolbox depends as much on preservation and adaptation as on the next breakthrough.
Latamoxef sodium comes from a class of drugs called cephalosporin antibiotics. Doctors reach for it during battles with tough bacterial infections. It owes much of its power to its strength against a range of harmful bacteria. In real-life hospital scenarios, bacterial infections show up in all sorts of places: patients on ventilators, folks recovering from surgery, children with fever who just won’t bounce back. Latamoxef sodium came about to tackle some of these stubborn bugs, including ones that don’t back down to milder antibiotics.
Some antibiotics play by old rules, but bacteria have grown smarter. Latamoxef sodium breaks down the bacteria’s cell walls, interfering with their construction crews at the most basic level. This drug has shown strong performance against everything from pneumonia to gut infections, skin wounds, and urinary tract troubles. It can handle gram-negative bacteria, notorious for causing life-threatening infections in hospitals.
Compared to common drugs like penicillin, latamoxef sodium holds its ground even when bacteria have learned resistance tricks. Doctors sometimes bring it in as a backup after simpler antibiotics stop working. According to published studies and experience from infectious disease specialists, it gave hope in outbreaks that left few other options on the table. In places with growing multi-drug resistance, having another weapon like this helps keep mortality rates down.
Drug resistance isn’t some future threat — hospitals watch it unfold every day. Medications like latamoxef sodium take on infections that don’t respond to older treatments. This drug keeps vulnerable patients—particularly those with weak immune systems—in the fight. In some countries, especially across Latin America and Asia, doctors turn to this antibiotic in cases of severe sepsis or after major abdominal surgeries. Its injectable form delivers medicine straight to the battlefield in the body, bypassing the digestive system for faster action.
Working around antibiotic resistance takes creative thinking and up-to-date research. The emergence of new ‘superbugs’ turns even routine infections into emergencies. Keeping a variety of antibiotics ready, like latamoxef sodium, helps doctors manage unpredictable situations in emergency rooms and intensive care units. No single drug works forever, so the medical community stays watchful, rotating antibiotics and monitoring bacterial patterns.
No antibiotic acts without risks. Latamoxef sodium can push the kidneys and liver, especially in kids or the elderly. Some patients feel side effects like digestive upset or rare allergic reactions. The drug’s strong action should only follow a clear medical need and the advice of a professional. Overuse or careless prescribing will speed up resistance, making the next infection even tougher to treat.
Hospitals track prescriptions closely, and governments keep antibiotics on tight controls for these reasons. Patients with a history of kidney issues, bleeding disorders, or allergies need extra supervision. One lesson from years in healthcare: trust between doctors, pharmacists, and patients makes or breaks treatment success. Open talk about drug side effects and realistic expectations shape safer, more effective care.
As frontline antibiotics lose their punch, every new medication gets a lot of attention. Stewardship programs, led by infectious disease experts, stress using the right drug, at the right dose, for the right time. Medical teams conduct follow-ups, review lab results, and update guidelines as germs evolve. Latamoxef sodium holds its place as a savvy choice for serious cases, helping tip the scales toward recovery when other meds fail. Modern medicine keeps pushing for new answers, but conserving the tools already in hand saves lives today.
Latamoxef Sodium doesn't belong among everyday painkillers or allergy tablets. It’s a strong antibiotic used mainly in hospitals, especially for folks battling serious infections that other medicines haven’t stopped. In my years volunteering at clinics, I’ve seen trust grow between patients and their care teams the moment a precise and often urgent medicine like this comes into conversation. Getting administration right isn’t just about dosage on a chart—it's a matter that can tip the scale between recovery and setbacks.
This medicine always comes as a powder, sealed in a sterile vial. Nurses and doctors draw it up and mix it with a particular type of liquid, usually sterile water or an approved saline. After giving it the right shake, they inject it directly into the vein either by slow injection with a syringe or set it up to run through an IV drip over time. Healthcare teams use precise measurements because this isn’t a drug that works by guesswork—too little and infection lingers; too much and the body might react badly.
You can’t pop a pill or rub on a cream with Latamoxef Sodium. Injections bring the drug into the bloodstream fast, so it heads straight for the infection. This rapid action can mean a world of difference with stubborn bacteria, especially those tough hospital-acquired ones. Medical teams keep a close eye on the patient, checking for allergic responses, soreness at the vein, and any shift in kidney function. I’ve seen frail patients go through the process, so I know it's not just about medicine but about human care: comfort, reassurance, and regular checks for complications.
Giving strong antibiotics through the vein isn’t as simple as setting an alarm for pills. It needs trained staff, clean settings, and working equipment. Rural clinics in low-resource regions fight real battles here—I’ve seen nurses improvise with limited supplies. The lack of ready IV gear can delay doses, which undercuts the fight against infection and feeds the problem of resistant bacteria. Mixed-up dosing schedules or improper preparation can risk side effects such as seizures or kidney stress, especially in the elderly or those with compromised immune systems.
Training nurses, investing in more supply kits, and updating ward protocols bring clear improvements. Even basic checklists help: double-check the drug, the patient, the line, and the time. Some hospitals where I volunteered built mini-courses just for mixing and giving rare drugs. Remote monitoring by pharmacists through secure chats keeps everyone up to date—even in smaller hospitals.
Latamoxef Sodium, strong as it is, works best with a skilled team using it carefully, respecting the patient, and catching any sign that the body isn’t handling things smoothly. Doctors, nurses, pharmacists, and yes, patients, all play a role in keeping these serious infections from turning into tragedies. Real progress follows when every link in the chain strengthens their piece of the process.
Latamoxef sodium belongs to the class of cephalosporin antibiotics, used for fighting off a range of bacterial infections. Hospitals and clinics often turn to this drug when treating pneumonia, urinary tract infections, skin infections, and blood infections. Working in healthcare, I’ve seen prescriptions filled for kids and adults alike, especially in places where resistance to older antibiotics crops up. This medication aims for bacteria and spares human cells, but no drug is perfect. Side effects still happen, and some people wind up feeling worse before they get better.
For some, the main issue comes after just a few doses: stomach trouble. Nausea, diarrhea, and stomach pain often top the list. One patient told me Latamoxef upset her stomach so much she could barely eat, even as her infection faded. Mild digestive complaints don’t usually mean the drug needs to be stopped, though dehydration can slip in if the person can’t keep food or liquids down.
Rashes and skin irritation do show up, too. Sometimes it looks like tiny red spots, and other times hives break out over larger areas. Allergic reactions can get serious. I’ve watched emergency doctors treat swelling, itching, or trouble breathing in someone after a dose. For anyone with a penicillin or cephalosporin allergy history, extra caution matters.
Latamoxef can quietly nudge blood tests off-kilter. Changes like low white blood cell counts or platelets pop up on routine tests. This means infections and bruises might crop up for some. Lab staff reach out quickly if changes look risky. I’ve seen doses adjusted or swapped based on these warning signs before the patient even feels different.
Liver and kidney numbers can shift as well. Jaundice, showing as yellow skin or eyes, sometimes alerts patients to a liver issue. Most folks never notice, but checking labs now and then helps providers catch problems early. For people with past liver or kidney trouble, close monitoring seems wise. Care teams usually keep tabs on these numbers, and if things go south, other options are available.
Anyone taking Latamoxef should know the signals for serious side effects: swelling, breathing trouble, dark urine, or bruising. It pays to mention any new rashes or stomach changes, too. Pharmacists and physicians work together to adjust doses or switch medicines as needed. Informing healthcare staff about allergies before treatment avoids many problems from the start.
Simple habits like staying hydrated and eating lighter meals help some folks weather mild side effects until treatment ends. Watching for warning signs at home—like fever that won’t quit—makes a difference, especially in kids and older adults.
Latamoxef sodium often clears tough infections that don’t budge with other antibiotics. For patients wrestling with fever and pain, that’s worth a lot, even with occasional side effects. Keeping lines of communication open with the healthcare team, getting regular blood tests, and practicing self-care at home all improve safety. While no medicine feels perfect, being prepared and aware gives patients a better shot at getting well without being sidelined by problems that can be spotted early.
Doctors sometimes reach for Latamoxef Sodium when common antibiotics can’t get the job done. This medication falls under the oxacephem group and treats tough infections, like complicated urinary tract problems, skin infections, and some respiratory issues. The drug works by knocking out the bacteria’s cell walls, leaving those bugs unable to cause more trouble. It’s considered pretty effective against a spread of Gram-negative bacteria—think E. coli or some Pseudomonas species—but any medicine that digs this deep calls for careful use.
Folks with allergies to beta-lactam antibiotics, such as penicillins or cephalosporins, should stay clear of Latamoxef Sodium. Even a past episode of hives, trouble breathing, or severe rash after these drugs points to a real risk of life-threatening reactions. I’ve seen patients underestimate these allergies, only to land in the ER with anaphylaxis. No one wins when that happens. Doctors usually dig through a person’s history, looking for these signs before starting the medicine.
Latamoxef Sodium gets cleared through the kidneys, so chronic kidney disease or dialysis puts someone at higher risk for serious side effects. Even small doses can build up in the bloodstream if the kidneys aren’t doing their job. I once cared for a man whose confusion and muscle twitches stemmed from drugs lingering too long because his kidneys were failing. Adjusting the dose—or finding another treatment—can move the needle in the right direction. People with severe liver trouble also need close monitoring, as the liver plays a role in breaking down most medications.
This drug sometimes nudges the body’s blood system in the wrong direction. Cases have popped up of people developing reduced platelets or white blood cells after receiving Latamoxef. Anyone already struggling with blood issues—think low platelets, easy bruising, or frequent infections—might see these problems get worse. Doctors often keep an eye on blood work if the course runs for more than a week, as it takes time for blood counts to dip.
Pregnant people should talk through risks with their provider. There’s not enough data showing the drug’s safety in pregnancy, so other options may take priority unless absolutely necessary. Also, Latamoxef contains a small amount of sodium. For folks with heart failure or severe high blood pressure, every extra bit of salt counts, and the care team should stay on top of total sodium intake.
Pharmacists often act as a last line of defense against inappropriate prescriptions. They cross-check allergies, kidney function, and medications that don’t mix well with Latamoxef, such as some diuretics or anticoagulants. By setting up real-time electronic alerts, many hospitals avoid preventable disasters. Continuing education for prescribers plays a role, too. Doctors, nurses, and pharmacists learn from the tough cases where contraindications slipped through the cracks.
Clear communication between patients and care teams cuts down on errors. People should keep an up-to-date list of allergies, chronic illnesses, and current medicines handy. Medical teams who slow down and explain the reasoning behind a choice inspire more confidence and fewer missteps. Introducing routine renal and hepatic function tests for anyone on powerful antibiotics might pick up problems early. In my practice, shared decision-making—not just box-checking—makes medicine safer.
Latamoxef sodium works as a strong ally in fighting tough infections. Labs and hospitals put their trust in this powder because it comes through in some urgent medical situations. Yet, the right results only show up if folks pay close attention to how they store it. Getting this wrong means wasted medicine, missed outcomes, and patients paying the price. This isn’t just another detail from a training sheet. It’s about keeping this medicine safe and strong—because lives, not just numbers, back up the reason for clear storage rules.
Latamoxef sodium crumbles under bad conditions. The facts don’t lie. This powder breaks down if someone lets it hang out in a hot, humid closet or under open light. Sure, the fancy pharmacy guides spell out the right numbers: 2°C to 8°C means standard refrigerator temps. In the real world, that means a fridge that shuts tight, a thermometer that works, and no leaving the powder out for a refill while chatting. I’ve seen good stock end up in the trash simply because a staffer left out a tray of vials “just for a bit” during shift handover.
If the powder sits out too long, moisture sneaks in, turning an expensive antibiotic into useless crumbs. This point matters more in rainy climates or older buildings where moisture likes to gather. Keeping desiccant packs in storage containers cuts down on risk. A sealed box feels simple, but it keeps out what ruins shelf life. Hospitals can waste thousands on ruined drugs every year from this one sloppy oversight.
Latamoxef sodium does not just dislike heat. Direct sunlight strips away what makes it effective. Most of us wouldn’t put milk on a sunny windowsill. Medicines deserve the same respect. Pharmacies that stock medications with tinted glass or pull-down shades offer a low-cost way to block light damage before it starts.
Labeling rules on boxes never replace staff who know their stuff. People rotate on and off shifts, interns fill in on weekends, and someone always ends up refilling the fridge. Hands-on training delivers more than a policy manual. New staff need to see why cutting corners means wasted time, ruined drugs, or worse—treatment failures. I’ve watched experienced pharmacists catch a problem just by running a finger over a box and feeling dampness. Knowledge like this travels fast if clinics treat training as a real investment, not just another checkbox.
Over-ordering brings its own hazards. Labs ignore expiration dates or stash products in the wrong spots, thinking they’ll “rotate it later.” Simple logging systems, counted inventory checks, and regular clean-outs stop powders like latamoxef sodium from just sitting there. Once the expiry date passes, don’t risk letting it slip into a patient’s treatment routine. Rushed nurses juggling a morning flurry shouldn’t have to play guesswork with what’s safe to use.
Reliable refrigerators, sealed containers, dry shelves, and blackout storage areas all shape how well latamoxef sodium holds up against humidity, heat, and light. The payoff shows in safer treatments and fewer headaches during audits. In my experience, investing in good storage up front saves more than just money—it saves trust when teams can say for sure that every vial pulls its weight, every dose does its job, and every patient gets the right shot at recovery.
| Names | |
| Preferred IUPAC name | sodium (6R,7R)-7-[(2R)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Other names |
moxalactam sodium Moxalactam disodium sodium latamoxef |
| Pronunciation | /ləˈtæməksɛf ˈsoʊdiəm/ |
| Identifiers | |
| CAS Number | 39337-61-4 |
| 3D model (JSmol) | `"3D model (JSmol)": "latamoxef sodium" = "CC1C2N(C(=O)C(S2)[C@@H]3SC(=C(C#N)C3=O)C(=O)[O-])C(C1S(=O)(=O)[O-])=O.[Na+].[Na+]"` |
| Beilstein Reference | 13626651 |
| ChEBI | CHEBI:63697 |
| ChEMBL | CHEMBL2104413 |
| ChemSpider | 33113702 |
| DrugBank | DB01329 |
| ECHA InfoCard | '03ca0d8a-63b0-4973-bc41-b3ea41fc4937' |
| EC Number | 26170-62-3 |
| Gmelin Reference | 73689 |
| KEGG | D08133 |
| MeSH | D008103 |
| PubChem CID | 6604094 |
| RTECS number | RO2020000 |
| UNII | J3U8G98L25 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C21H21N4NaO10S2 |
| Molar mass | 625.48 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.9 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -2.22 |
| Acidity (pKa) | 2.6 |
| Basicity (pKb) | 6.3 |
| Magnetic susceptibility (χ) | -27.3e-6 cm³/mol |
| Dipole moment | 3.45 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 342.1 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01DD07 |
| Hazards | |
| Main hazards | May cause sensitization by inhalation and skin contact. |
| GHS labelling | GHS labelling of Latamoxef Sodium: `"Warning; H315; H319; H335; P261; P305+P351+P338"` |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary statements | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. |
| NFPA 704 (fire diamond) | NFPA 704: 2-3-1 |
| Lethal dose or concentration | LD50 mouse (intravenous): 2370 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Latamoxef Sodium: ">5 g/kg (oral, mouse) |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 1–2 g every 12 hours |
| IDLH (Immediate danger) | Not listed. |
| Related compounds | |
| Related compounds |
Moxalactam Cefotaxime Ceftriaxone Cefoperazone Cefuroxime |
